RobinM.ShawMDPhD

Adult Congenital Heart Disease, Heart Failure & Transplantation

Wasserman Endowed Chair in Cardiology, Cedars-Sinai Medical Center and UCLA

Dr. Shaw is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8700 Beverly Blvd
West Hollywood, CA 90048
Phone+1 310-423-5000

Fax+1 310-967-1773

University of California (San Francisco)Fellowship, Cardiovascular Disease, 2001 - 2004
University of California (San Francisco)Residency, Internal Medicine, 1999 - 2001
Case Western Reserve University School of MedicineClass of 1999

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

PubMed

AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model.
Muhammad S Khan, Douglas Smego, Jing Li, Yuki Ishidoya, Emmanuel Offei
Communications Medicine. 2025-03-27
A truncated isoform of Connexin43 caps actin to organize forward delivery of full-length Connexin43.
Rachel Baum, Vu D Nguyen, Mario Maalouf, Daisuke Shimura, Miriam Waghalter
The Journal of Cell Biology. 2025-03-03
Design of the First in Human Gene Therapy Trial of TLT-101 for Chronic Heart Failure (FIGHT-HF).
Pia Balmaceda, Tara C Hitzeman, Kikuyo E Shaw, Lynn M Kolhepp, Matthew Killeen
JACC. Basic to Translational Science. 2025-03-01

Journal Articles

The Clinical Course of a Genetic Dilated Cardiomyopathy
Robin Shaw, MD, ScienceDirect

Heart Failure Is Reversed with New Gene Therapy in Animal Study: ‘Unprecedented Recovery’December 11th, 2024
Gene Therapy Reverses Heart Failure in New TrialsDecember 10th, 2024
Gene Therapy Reverses Effects of Heart Failure and Restores Heart Function in MinipigsDecember 10th, 2024
Join now to see all

Novel Gene Therapy For Chronic Ischemic Heart FailureUNIVERSITY OF UTAH2024–2027
Novel Gene Therapy For Chronic Ischemic Heart FailureUNIVERSITY OF UTAH2024–2027
Correcting Cardiac Microdomains Reverses Non-Ischemic CardiomyopathyUNIVERSITY OF UTAH2023–2027
Training in Cardiovascular ResearchUNIVERSITY OF UTAH1994–2027
Training in Cardiovascular ResearchUNIVERSITY OF UTAH1994–2027
Training in Cardiovascular ResearchUNIVERSITY OF UTAH1994–2027
Training in Cardiovascular ResearchUNIVERSITY OF UTAH1994–2027
Training in Cardiovascular ResearchUNIVERSITY OF UTAH1994–2027
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1UNIVERSITY OF UTAH2021–2025
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1UNIVERSITY OF UTAH2021–2025
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1UNIVERSITY OF UTAH2021–2025
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1UNIVERSITY OF UTAH2021–2025
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1UNIVERSITY OF UTAH2021–2025
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1UNIVERSITY OF UTAH2021–2025
Unlocking Trafficking Specificity for Cx43 Gap JunctionsUNIVERSITY OF UTAH2020–2025
GAP Junction Trafficking To And Within The Plasma MembraneNational Heart, Lung, And Blood Institute2009–2012
Excitability Between Cardiac And Non-Cardiac CellsNational Heart, Lung, And Blood Institute2005–2009